[3H]Diazepam displacing activity in human cerebrospinal fluid

Area of Science:

• Neurochemistry
• Pharmacology

Background:

• Human cerebrospinal fluid (CSF) contains various biomolecules.
• Benzodiazepine receptors are crucial targets for neurological drugs.

Purpose of the Study:

• To characterize endogenous ligands for benzodiazepine receptors in human CSF.
• To isolate and identify compounds exhibiting [3H]diazepam displacing activity.

Main Methods:

• Sephadex G-50 chromatography of pooled human CSF.
• Monitoring absorbance at 254 and 280 nm to detect fractions.
• Membrane receptor binding assays using [3H]diazepam.
• Further purification of active fractions using Bio-Gel P-4 chromatography.

Main Results:

• Three distinct peaks (A, B, C) were observed after initial chromatography.
• All peaks demonstrated [3H]diazepam displacing activity.
• Peak B yielded at least two major fractions (MW 700-3600) with displacing activity.
• GABA (gamma-aminobutyric acid) enhanced the activity of these fractions by threefold.

Conclusions:

• Human CSF contains endogenous substances that interact with benzodiazepine receptors.
• Purified fractions from CSF exhibit specific binding to these receptors.
• The presence and activity of these ligands may be modulated by GABA.